personal genomics, personalized medicine, you · personal genomics, personalized medicine, &...

20
Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21 st May 2012 AAAS/Science Translational Medicine panel discussion; MLA 2012

Upload: trantruc

Post on 04-Jun-2018

222 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Personal Genomics, Personalized Medicine,

& YOU

Carrie Iwema, PhD, MLS

21st May 2012

AAAS/Science Translational Medicine panel discussion; MLA 2012

Page 2: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Timeline: Human Genome Sequence

HSLS, U.Pitt

1995 2014

2000

2003

2007

2007

2010

Human Genome Draft Sequence

Complete Human Reference Genome

Individual Human Diploid Genome

Jim Watson’s Genome

$2.7 B 13 yrs

$24 K 15 days

$1 M 1 mth

$1K 15 mins

1st sequenced genome of a free living organism:

Haemophilus Influenzae

Page 4: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Why get genetic testing?

HSLS, U.Pitt

Ideas for more tests and interventions if I

learn I’m at risk

To find the right drugs, in the right doses, for

my conditions

Motivation to change my habits

Might reveal details of my family tree and

genealogy

Planning for my long term medical and financial needs

I am an early adopter and information altruist

I want to use my genome as a social

networking tool

To inform my reproductive decisions

personal genetics education project (link)

Page 5: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

• 23andMe: genetics just go personal.

– Ancestry Edition $399

– Health Edition $429

• Navigenics: clinically guided genetic analysis – Prices vary; special rates through physicians/employer

• Pathway Genomics: The Value of Knowing – Must be ordered through a U.S. physician registered w/PG

• deCODEme: deCODE your health – Complete scan (47 conditions) $2,000

DTC: Major Companies (20-30K scans in 2009)

HSLS, U.Pitt

$99+

Page 7: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

SNP: single nucleotide polymorphism

HSLS, U.Pitt

– DNA sequence variations that occur when a single nucleotide (A, C, T, G) in the genome sequence is altered

– Variations in DNA sequence have an impact on how humans respond to disease

– Must occur in at least 1% of the population

– SNP maps help identify genes associated with complex ailments

Page 8: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

• NIH-supported research

• January 2008

• Comparison of genomes to determine individual variations

• dbGAP = database of Genotype & Phenotype (NCBI)

• Results will help develop better diagnostic tools & treatments

GWAS: Genome Wide Association Studies

HSLS, U.Pitt

Page 9: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Next Gen Sequencing (NGS)

HSLS, U.Pitt

Page 10: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

• How an individual’s genetic inheritance affects the body’s response to drugs

– More powerful medicines

– Better, safer drugs appropriately matched to patients

– More accurate drug dosages

– Advanced screening for disease

– Better vaccines

– Decrease in overall health care costs

– Improvements in drug discovery & approval process

Pharmacogenomics

HSLS, U.Pitt

Page 11: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

• HER2 oncogene

• Over-expressed in 25-30% patients

• Results in increase in replication of cancer cells

• Treat w/Herceptin, a monoclonal antibody that inhibits HER2

BENEFITS

– Herceptin targets ONLY cancerous cells, thus eliminating need to administer large drug doses

– Identification of ONLY patients w/gene over-expression, thus preventing unnecessary treatments

Example—breast cancer

HSLS, U.Pitt

Page 12: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

– Walgreens, Pathway

Genomics, & FDA (May 2010)

– Government Accountability Office (GAO) • 22 July 2010

• DTC genetic testing companies provide “results that are misleading and of little or no practical use.”

• Companies: 23andMe, Navigenics, Pathway Genomics + others

– Degree of Regulation vs Public Right to Personal Info

Congress & DTC

HSLS, U.Pitt

Page 13: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

1. Ensure appropriate info & consent procedures

2. Formal laboratory accreditation

3. Evidence of a valid gene-disease association

4. Appropriately qualified staff to interpret the test result

5. Consumer protection legislation to prevent false or misleading claims

Regulating direct-to-consumer genetic tests: What is all the fuss about?

Wright CF, Hall A, Zimmern RL.

Genet Med. 2010 Oct 1. [Epub ahead of print] PMID: 20921893

Suggested Regulation

HSLS, U.Pitt

Page 14: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Challenges

HSLS, U.Pitt

What are the privacy concerns

for individual and families?

How much should we fear

discrimination at work and with

insurance?

How far ahead is the technology of its clinical usefulness?

Will fair weight given to

environmental & social factors?

How can we ensure access for all who want to be sequenced?

What surprises and secrets might

be revealed?

How realistic are promises of

anonymity?

personal genetics education project (link)

Page 15: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

GINA: Prohibits genetic discrimination

in health insurance & employment

HSLS, U.Pitt

Title 1: Prohibits discrimination in group and individual health insurance plans. Forbids genetic information being used to deny coverage, adjust premiums, or require someone to take a genetic test.

Title 2: Prohibits employers from using genetic information to make hiring, firing or promotion decisions. Severely limits employers rights to request, require, or purchase an employee’s genetic information.

California… Genetic Information Non-discrimination Act May 2008

Page 16: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Newsweek August 2-6, 2010

– Mary Carmichael—”DNA Dilemma”

– What can be learned from these tests?

• Conclusion: tests can be educational, but medical value is debatable

– How reliable are they and how will I react?

• Conclusion: carefully choose the company, avoid hype, engage w/your data, consult w/expert(s), recognize still early days of personal genomics

– Should these tests even be on the market?

• Conclusion: regulation is inevitable, but to what extent; individuals have the right to access their own genetic info; transparency

– Final decision

To take a genetic test or not—that is the question…

HSLS, U.Pitt

Page 17: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Mom the worrier

You

Crazy Uncle Bill

Skeptical brother

Early adopter sister

Dad already signed up to get sequenced

Grandpa says no way!

Aunt Erma worried about losing her insurance because of her son’s DNA sequence

Cousin Betty wants to donate her sequence to science and make it totally public Grandma is

gone, but a sample of her DNA still exists…

Impact on Family

HSLS, U.Pitt

personal genetics education project

(link)

Your kids

Your potential kid?

Page 18: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

• Talk to the company’s genetic counselors

• Talk to your physician

• Do it yourself…?

– SNPedia: wiki investigating human genetics

– Promethease: uses SNPedia to analyze & help explain your DNA

I’m doing it!

HSLS, U.Pitt

So you’ve got your sequence…now what?

Page 20: Personal Genomics, Personalized Medicine, YOU · Personal Genomics, Personalized Medicine, & YOU Carrie Iwema, PhD, MLS 21st May 2012 AAAS/Science Translational Medicine panel discussion;

Thanks for your attention.

Carrie Iwema, PhD, MLS

Information Specialist in Molecular Biology

Health Sciences Library System

University of Pittsburgh

[email protected]